A decreased cellular immunity is characteristic of GBM, to which an increased proportion of Tregs among CD4+ TIL (tumour-infiltrating lymphocytes) has been shown to contribute both in patients63,64 and in pre-clinical models65,66. The gene discussed is CD4; the disease is neoplasm.